Systematic Anatomical Description of the Female Pelvic Retroperitoneum in Cadavers (RETRO-PELVIS)

July 18, 2026 updated by: Jorge García Fernández, Hospital Universitari de Bellvitge

Systematic Anatomical Description of the Female Pelvic Retroperitoneum in Cadavers: A Descriptive Study for Gynecologic Surgery

This observational descriptive cadaveric study aims to describe the main anatomical relationships of the female pelvic retroperitoneum using standardized anatomical dissection. Adult female cadavers obtained from an institutional body donation program will undergo pelvic retroperitoneal dissection. Ten predefined anatomical relationships involving the ureter, pelvic vessels and nerves will be evaluated using a standardized anatomical checklist. Anatomical variability will be described for each item. Standardized photographs will also be obtained to develop an anatomical atlas for educational purposes.

Study Overview

Detailed Description

This is an observational, descriptive cadaveric study designed to characterize the main anatomical relationships of the female pelvic retroperitoneum with direct application to gynecologic surgery.

The study will be conducted using adult female cadavers obtained from an institutional body donation program. Approximately 20 cadavers will be included, depending on availability, providing a total of 40 hemipelves. Each hemipelvis will be considered an independent unit of analysis.

Standardized anatomical dissections of the pelvic retroperitoneum will be performed following a predefined protocol. The main anatomical structures relevant to gynecologic surgery will be identified, including the pelvic ureter, iliac vessels and their branches, obturator nerve, and other predefined anatomical landmarks.

Each hemipelvis will be evaluated using a standardized 10-item anatomical checklist. For every item, the reference anatomical pattern will be classified as present ("Yes"), absent ("No"), or not evaluable ("Not evaluable"). Anatomical variability will be calculated as the proportion of anatomical variants among all evaluable hemipelves for each item.

Standardized photographic documentation will be obtained throughout the dissections. Anatomical variants will be qualitatively described and illustrated whenever possible.

Statistical analysis will be descriptive. Categorical variables will be presented as absolute frequencies and percentages. Anatomical variability will be reported for each checklist item, excluding non-evaluable observations from the denominator.

This study does not involve living human participants, clinical interventions, or identifiable personal data. All procedures will be conducted in accordance with institutional and ethical standards governing the use of donated human bodies for research and education.

The expected outcome is a systematic description of the principal anatomical relationships of the female pelvic retroperitoneum and their anatomical variability, together with the development of a photographic anatomical atlas to support surgical training and gynecologic education.

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Jorge Garcia Fernandez Principal Investigator, Gynecologist
  • Phone Number: +34622595644
  • Email: jorgarciafernan@gmail.com

Study Locations

      • Barcelona, Spain, 08028
        • Not yet recruiting
        • Universitat de Barcelona - Department of Anatomy and Human Embryology
        • Contact:
          • Josep Maria de Anta Vinyals Chief of Department Anatomy and Embriology, Anatomist
          • Email: janta@ub.edu
    • Barcelona
      • Barcelona, Barcelona, Spain, 08007
        • Recruiting
        • Universitat de Barcelona - Department of Anatomy and Human Embryology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult female cadavers from the institutional body donation program.

Description

Inclusion Criteria:

  • Female cadavers from an institutional body donation program
  • Age ≥ 18 years at time of death
  • Adequate preservation of pelvic and abdominal retroperitoneal structures
  • Anatomical integrity allowing identification of the pelvic ureter, iliac vessels and their main branches, obturator nerve, and other structures included in the anatomical checklist.
  • Availability of both hemipelves for comparative analysis
  • Authorization for research use according to institutional body donation regulations

Exclusion Criteria:

  • Male cadavers
  • Prior major pelvic or abdominal surgery significantly altering retroperitoneal anatomy (e.g., hysterectomy, lymphadenectomy, vascular surgery)
  • History of pelvic or abdominal radiotherapy
  • Advanced pelvic or abdominal malignancy with retroperitoneal involvement
  • Severe trauma affecting pelvic or abdominal anatomy
  • Poor preservation or significant tissue degradation
  • Absence of one or both hemipelves
  • Advanced pregnancy at time of death

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cadaveric Specimens
Adult female cadavers obtained from an institutional body donation program. Specimens will undergo standardized pelvic retroperitoneal dissection, completion of a predefined 10-item anatomical checklist, and photographic documentation.
Standardized pelvic retroperitoneal dissection with completion of a 10-item anatomical checklist, observations and photographic documentation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of anatomical variation
Time Frame: Baseline
Percentage of anatomical variation for each of the ten predefined anatomical relationships evaluated using a standardized anatomical checklist.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development of an anatomical atlas
Time Frame: Baseline
Standardized photographic documentation of anatomical structures and variants for educational purposes.
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Development of an Applied Anatomical Atlas
Time Frame: through study completion, an average of 1 year
Integration of morphometric measurements and standardized photographic documentation to develop a clinically oriented anatomical atlas of the female pelvic and lower abdominal retroperitoneum for educational and surgical applications.
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jorge García Fernández, Gynecologist, Hospital Universitari de Bellvitge

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2026

Primary Completion (Estimated)

September 28, 2026

Study Completion (Estimated)

November 30, 2026

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

April 3, 2026

First Posted (Actual)

April 13, 2026

Study Record Updates

Last Update Posted (Actual)

July 21, 2026

Last Update Submitted That Met QC Criteria

July 18, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared because this study does not involve living participants or identifiable individual-level clinical data. The study is based on anonymized cadaveric specimens and generates aggregate anatomical and morphometric data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Anatomy

Clinical Trials on Anatomical Dissection

Subscribe